That is very important, because the way a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and work. To put it simply, we need to know how these proteins fold if we want a drug to work. Historically, this has actually been an experimental procedure (tech predictions). Today, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to produce drugs that do what they're designed to do. This was a breakthrough practically nobody discovered. But it's going to have profound ramifications for treating illness. I forecast that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be a lot of financial investment chances in this area, too. Shifting subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (united states). That stated, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be shocked if it drew back maybe considerably prior to going greater - jeff brown investment prediction. I've been covering bitcoin for a long period of time now. Among the very first research reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary suggestion, I titled my report "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time. We were mainly educating readers. However that's not the huge question anymore. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. Mass, Mutual is a relied on 170-year-old institution. So believe about that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a huge factor I'm bullish on it this year. jeff brown 2021 stock picks. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These companies raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are many great personal business on the edge of hitting the public markets And I have actually been working on a brand-new method for you to invest even prior to these companies go public.
This chance has actually been constructing over the last few years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the details. Go right here to reserve your area totally free.
Emma Walsh here, handling editor of the Diary. Regular Journal readers understand that tech isn't our usual beat (brownstone research). And when it concerns tech investing, we leave it to the experts. The good news is, we have several such specialists in our Rolodex. Our colleague Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing experts we understand (exponential tech investor). In reality, he had numerous triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the huge image and forecast what's simply around the corner.
That consists of things like 5G networks, biotech, artificial intelligence, and far more. These trends are experiencing exponential growth and creating extraordinary opportunities for investors. I want to make certain all our readers are prepared for what's next. And with that in mind, let me draw the photo of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. jeff brown stock predictions. However regardless of what numerous readers might believe, this is a trend that's simply getting started. Even though the COVID-19 pandemic disrupted supply chains last year, an outstanding 250 million 5G-enabled gadgets were still offered.
And all of this ultimately led to Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown 2020 predictions). Losing 2 months of production and sales really affects the number of 5G devices are offered in the calendar year. When you consider all of that, offering 250 million units is exceptional. More importantly, the hold-ups brought on by the pandemic created a lots of bottled-up need. Which demand is now going to be pushed into 2021. In truth, I predict that more than 500 million 5G devices will be shipped in 2021 - jeff brown stock predictions. And that's not my only 5G forecast When I have actually discussed 5G in the past, I've explained its 3 different phases.
In Phase 2, 5G devices go on sale. 5G phones and other items start to reach consumers. And in Stage 3, 5G services begin to be provided (jeff brown genome sequencing stock). That's when we begin to see applications operating on 5G networks. Think about things like enormous multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will start Phase Three by this summertime. This begins something of a virtuous cycle: The majority of individuals don't truly care about the innovation. However they will care if there are interesting applications that can only be accessed with a 5G phone.
That leads to more 5G apps being developed. In fact, 5G is going to open a suite of amazing applications: self-driving vehicles, the Internet of Things, robotic surgery, and more. All of these technologies require 5G. The financial investment chances going forward will be enormous. Stepping away from 5G, the next essential innovation I foresee in 2021 is CRISPR genetic modifying. CRISPR means "clustered regularly interspaced brief palindromic repeat." It's a mouthful. But it is among the most exciting advancements in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software application.
The program can crash or not operate correctly. CRISPR utilizes a comparable concept but with our hereditary code. "Typos" in our genome can lead to disease. CRISPR can correct these "typos." For years, CRISPR was mainly a niche technology that wasn't well comprehended. And during that time, there were actually just 3 business running in this space. But things are altering. CRISPR is no longer just theoretical. We're seeing actual outcomes. We're dealing with illness and seeing that this technology just works. And as a result, a "2nd crop" of early-stage CRISPR business is going public and delivering amazing returns. This whole industry is successfully a greenfield chance.
There's room for lots of business to exist in this space. biotech stocks. And there will be more. That's my prediction for CRISPR in 2021. I predict that 2 or 3 more hereditary editing companies will hold their IPOs. Sticking with biotechnology, we are seeing amazing things occurring at the merging of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its latest Alpha, Fold software can precisely predict the folding of a protein based solely on its amino acid sequence with 92. 4% accuracy. That is essential because the way a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has been a trial-and-error process. Now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much easier to produce drugs that do what they're designed to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however a number of drug treatments produced utilizing this innovation. This was among those developments that almost nobody noticed. But it's going to have extensive ramifications for curing illness. And, obviously, there will be plenty of investment opportunities in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be surprised if it pulled back maybe substantially prior to going higher. I've been covering bitcoin for a very long time now. Among the first research study reports I ever released was on bitcoin - jeff brown predictions for 2021. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anyone who followed my suggestion. However at the time of that initial suggestion, I titled my report, "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time.
But nobody is asking that question anymore. Now, we're seeing institutional cash finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. angel investor. Mass, Mutual is a 150-year-old institution. So consider that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another benefit forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and claims the info depends on date since February 2021, but we could not independently confirm this claim. Provided Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down an accurate figure at this moment. Brown is best known for his sage-like ability to pick winning technology stocks. He spent more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an exceptional perspective on the marketplace. He's constantly on the hunt for new chances, and he shares a number of his best choices in the Near Future Report.
That's high appreciation, but it's not ridiculously reasoned. Brown has an excellent credibility as a stock-picker, and he effectively forecasted a few of the most significant financial events of the previous twenty years. Although he doesn't appear to launch his choices to the public, the service's success is a direct indicator of Brown's stock-picking expertise. Nobody on Wall Street gets it right every time, but Jeff Brown's precise predictions have made him legions of devoted fans. That states a lot about his ability. The Near Future Report is published by Brownstone Research, a popular monetary research publisher. Brownstone Research study provides a number of research services with a variety of specializations - jeff brown biotech stocks.
The business is likewise affiliated with Bonner & Partners, another well-respected research publisher - jeff brown biotech picks. On its site, Brownstone states its mission is to offer retail financiers with professional-grade research: "For too long, the finest investment research study has not been available to specific financiers. It has actually been typically scheduled for investment banks, hedge funds, personal equity, and high-net-worth customers. united arab emirates. The mission of Brownstone Research is to make that type of exclusive research readily available to any investors looking to acquire an edge in the markets. The goal is basic to deliver distinct and successful financial investment research found nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research, and he also serves as the company's Chief Financial investment Analyst.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to provide its clients. After years of constant success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a family name throughout the majority of America. If you understand even a bit about the marketplace, you understand that he has a credibility as a King Midas of sorts. jeff brown 1 biotech company. Whatever he touches relies on gold! Jeff is well mindful of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge project.
In reality, Brown believes S.A.V. exponential growth. could be "the biggest pattern of the 2020s, and he's not alone. Check out these quotes from other widely known S.A.V. bulls: Elon's next huge act will be marrying 2 innovative technologies: expert system and electrical vehicles. Musk hopes the mix will assist him develop the very first fully-autonomous, self-driving cars and trucks ever. It's absolutely nothing brief of the automobile industry's Holy Grail. As you know, electrical lorries and self-driving vehicle stocks have been big this year, however the Wall Street device has approved buzz without much tangible outcome. Despite an extreme increase in competitors over the past couple of years, Brown still believes Musk has the very best chance of putting it all together.
tech might be the magic string that connects it all together. S.A.V. means Shared Autonomous Automobile, and it could be the future of transport. Basically, this technology would permit you to rent your car as a self-governing, self-driving taxi when you're not using it. You merely leave the vehicle and press a button on an app that tells the vehicle to "join the fleet." Next thing you understand, you're relaxing on your sofa while your car shuttles ride-sharers around town. Most importantly, you get to keep a substantial portion of the earnings. It sounds ridiculous, however it could be closed than you believe.